Alignment Healthcare/$ALHC

1D1W1MYTD1Y5YMAX

About Alignment Healthcare

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Ticker
$ALHC
Sector
Health
Primary listing
NASDAQ
Employees
1,849

ALHC Metrics

BasicAdvanced
$1.6B
40.13
$0.20
1.11
-

What the Analysts think about ALHC

Analyst ratings (Buy, Hold, Sell) for Alignment Healthcare stock.
Analyst projections of the future price of Alignment Healthcare stock.

Bulls say / Bears say

The second quarter showed strong commercial momentum: Medicare Advantage membership rose 31.5% year on year to about 294,100, while revenue increased 31.6%. Alignment raised its 2026 membership and revenue outlook after beating the high end of its key quarterly targets. (Alignment Healthcare)
The company is beginning to show operating leverage as it scales. Second-quarter adjusted EBITDA rose 48.4% to $68.1 million, the adjusted EBITDA margin expanded to 5.1%, and the medical benefits ratio improved to 86.3%. (Alignment Healthcare)
About half of the membership is still in its first or second year, giving Alignment a potential profit tailwind as members mature and clinical programmes take effect. Management estimates roughly $880 million of embedded adjusted gross-profit potential in the current membership base. (The Motley Fool, The Lincolnian Online)
Management said hospital and skilled-nursing costs remained elevated into July and August, with disputed older bills and longer nursing-home stays. A claims-system conversion also caused a reserve hit of more than $6 million, while another $10 million to $11 million of second-half spending is planned. (Stocktwits)
Medicare Advantage star ratings and risk-adjustment rules remain a material source of uncertainty. Alignment’s chief executive called the legal and regulatory footing around star benchmarks shaky, while 2027 payment growth is forecast at only 2.48% after a 2.65% reduction from risk-adjustment changes. (The Motley Fool, Avalere Health)
Growth is shifting towards higher-acuity chronic-condition and dual-eligible members, which initially carry higher medical costs. Management expects only about 30% of full-year adjusted EBITDA in the second half as it absorbs this mix and invests further in clinical operations, automation and market preparation. (The Motley Fool, Zacks)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.

ALHC Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

ALHC Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing ALHC

AllEURUSDGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.